Here are some developments:
• Cellvizio received MHLW regulatory approval in Japan in April 2014 and is now installed in 10 leading hospitals throughout the country including the National Cancer Center Hospital in Tokyo.
• Dr. Ken Ohata, director of endoscopy at NTT Medical Center Tokyo, performed the first-ever live procedure involving the use of Cellvizio in Japan on March 7.
• More than 25 leading physicians from Japan will take part in the upcoming International Conference of Cellvizio Users to be held in Lisbon on April 10.
More articles on GI/endoscopy:
Removing Barriers to Colorectal Cancer Screening Act introduced: 5 things to know
7 things for gastroenterologists to know for today – March 16, 2015
Norgine, Arc Medical partner to distribute colonoscopy device ENDOCUFF VISION
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.